ArticleMolecules (Basel, Switzerland)2016

Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells.

Xiao-Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.